The Latest Breaking News from BofA

Ford Motor Company (NYSE:F) shares are trading higher on Thursday after the automaker posted second-quarter results that exceeded Wall Street expectations on Wednesday, driven by solid vehicle volumes and favorable pricing trends.

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

Morgan Stanley (NYSE:MS) on Wednesday reported a second-quarter 2025 earnings of $2.13, up from $1.82 a year ago and beating the consensus of $2.02.

The FTSE 100 index closed down 11.77 points, 0.1%, at 8,926.55.

Americans adopted roughly 23 million pets during the pandemic, and Bank of America Research sees the "COVID cohort" nearing middle age.

The U.S. stock market has just completed one of its strongest three-month runs in history, with the SP 500 soaring 26% between April 9 and July 10, a pace of gains rarely seen. While historical analogues suggest further upside, signs of overheated investor sentiment are starting to worry market watchers.

BofAmerica Securities analyst Andrew Obin maintained a Buy on Honeywell International (NASDAQ:HON) and increased the price target from $250 to $275 on Monday.

Bristol-Myers Squibb Co. (NYSE:BMY) is gearing up to announce its second-quarter 2025 earnings on July 31, with expectations for adjusted earnings of $1.585 per share on sales of $11.31 billion, according to data from Benzinga Pro.

Southwest Airlines Co. (NYSE:LUV) plans to expand its route network in 2026, starting with new service to Cyril E. King International Airport (STT) in St. Thomas, U.S. Virgin Islands.